We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Instem Plc | LSE:INS | London | Ordinary Share | GB00B3TQCK30 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 830.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
15/10/2010 15:18 | some buying now up 5% | andrbea | |
13/10/2010 10:22 | what we got here then andrbea ? ;-) | jab118 | |
13/10/2010 08:54 | COMMENCEMENT OF DEALING IN SHARES Instem Life Science Systems plc (AIM:INS.L), a leading provider of IT applications to the global early development healthcare market, is pleased to announce that dealings will commence today in its Ordinary Shares following its admission to AIM, under the ticker INS. Instem has raised £9.15 million (prior to expenses) through a placing by Brewin Dolphin of 5,228,376 new Ordinary Shares at the placing price of 175p per share. Following the placing, there will be 11,714,286 Ordinary Shares in issue, giving Instem a market capitalisation of £20.50 million at the placing price. The percentage of Ordinary Shares in public hands on Admission will be approximately 45 per cent. Based in Staffordshire, Instem is the leading provider of Early Development Safety Assessment software, providing its services to over 80 customers, including seven of the top ten global pharmaceutical and biotech companies. The Company has in place a reputable and established business, primarily in North America, Europe and the UK, and expects to grow organically, and where appropriate, acquisitively to accelerate its growth trajectory. General market drivers such as increased R&D productivity requirements, increasing regulatory pressure, growing Far Eastern markets and the ongoing trend to outsource are expected to drive increased demand for Instem's solutions. Phil Reason, CEO of Instem Life Science Systems plc, commented, "We have been delighted with the response from investors and believe AIM will provide us with an excellent platform as we seek to further our market leading position through both organic and acquisitive growth." | andrbea | |
13/10/2010 08:48 | New float LONDON -(Dow Jones)- Healthcare IT company Instem Life Science Systems PLC said Monday it is to raise GBP9.15 million in an initial public offering on London's junior Alternative Investment Market. Instem, which makes management software used by drug makers like GlaxoSmithKline PLC (GSK.LN), said it intends to use the money raised to pay for acquisitions, launch new products and boost its presence in Japan and China. The company said dealings in its shares are expected to start on Oct. 13. Brewin Dolphin is the company's nominated adviser and broker. Instem said it expects to have a market capitalization on admission of GBP20.5 million. | andrbea | |
05/1/2010 16:26 | free stock charts from www.advfn.com | jamdon2 | |
17/11/2007 22:13 | i would not sell my few. | valter | |
29/7/2007 10:28 | i think they have to keep the offer open, or up it. | valter | |
28/7/2007 13:48 | No they have a majority now. They could actually drop the offer, but they probably will keep it level. My advice is to get rid of them now before you get stuck with dead shares that you can only redeem via the registrar. DYOR etc. | joestalin | |
24/7/2007 22:54 | they may have to up the offer? | valter | |
22/7/2007 16:47 | I think I'm correct in saying now that if you don't actually vote 'No' within your nominee account before 24th July, your broker will vote 'Yes' on your behalf. Correct me if I'm wrong.... | slj | |
21/7/2007 12:02 | woman on 'phone wanting to know why i have not taken up the recomended offer! told her i did not like the offer and would only take it when it bcomes compulsary. she was miffed. | valter | |
11/7/2007 12:57 | Thanks Joe. Well I will stand firm then - that said if they do manage a compulsory takeover would those of us who stand firm get < the 63p offered? | renaissance | |
11/7/2007 09:49 | hotpennystocks.us ??? Now that would not be a boiler room harvest, would it? | joestalin | |
11/7/2007 09:47 | what happens if I don't accept their offer of 63p? Then they may not get the required number of shares to get a compulsory take over. They may be forced to pull out of the TO or up their bid, preferably the latter. It needs a lot of dissenters to stand firm though. | joestalin | |
10/7/2007 19:56 | Forgive my ignorance but now that they have been declared unconditional, what happens if I don't accept their offer of 63p? | renaissance | |
09/7/2007 17:02 | Trafalgar Asset Managers Ltd continuing to increase their holding, paying above 63p for their shares. They've been buying every day for the past week - they now hold 12.81%. Anybody have any idea what could be behind their action? | slj |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions